.png?width=4560&height=656&name=Website%20(8).png)
Research
Original, data-rich research that equips healthcare leaders with
authoritative insights into trends shaping the health economy.
authoritative insights into trends shaping the health economy.
%20(1).png?width=7120&height=5648&name=HPPT%20White%20Paper%20(3)%20(1).png)
Health Plan Price Transparency
Leveraging Transparency in Coverage Data to Reveal Actionable Information on Commercial Negotiated Rates
Our newest report analyzes health plan price transparency data to examine unexplainable differences in healthcare prices.

ABA Therapy Utilization Grew Nearly 300%, Driven by Increases in Medicaid
Read More

State Hospital Pricing Law Signals 2026 Legislative Activity and Potential Federal Reform
Read More

High Polypharmacy Rates Underscore Pharmaceutical Reliance
Read More

Cash Rates Are Often Lower Than Negotiated Rates for Common Hospital Services
Read More

Limited Network Options Offered to Employers Can Result in Thousands More for the Same Healthcare Service
Read More

2025 Labor and Delivery Closures Disproportionately Affect Smaller Hospitals Serving Roughly One-Third of Local Births
Read More

Growth in Emerging Chronic Conditions Signals a General Sense of Unwellness
Read More

Projected Population Change and Market-Level Incidence Rates Influence Healthcare Demand
Read More

Hospital Administrative Expenditures Exceed Direct Patient Care by Nearly 2x
Read More

How Regression to the Mean in Commercial Rates Would Impact Healthcare Costs
Read More

Younger Adults and Women Drive Growth in Nutrition Services
Read More

Market Trends in Private Equity-Backed Healthcare, With Insights From Home Health
Read More

The Proposed Elimination of the Inpatient Only List Will Further Accelerate the Shift of Surgeries to Outpatient Settings
Read More

Surgical Procedures Are Increasingly Imperiled by New Pharmaceuticals
Read More

Minnesota's Novel 340B Financial Reporting Program Reveals Revenue Concentration Among Disproportionate Share Hospitals and Specialty Medications
Read More

Winning in an Outpatient World: Preparing for Potential Changes to Medicare’s IPO List
Read More

Antibiotic Overprescribing Remains High in Certain Provider Types, Care Settings and Regions
Read More

Medicare Advantage Utilization Remained Relatively Flat from 2022 to 2023, While Utilization by Care Setting Was Variable
Read More

Despite Regulatory Scrutiny, Increases in Adult ADHD Diagnosis and Off-Label Stimulant Prescribing Continued Through 2023
Read More

Changes in Coding Intensity Across Outpatient Settings
Read More

Outpatient Utilization Rates in Cancer Care Reflect Procedure-Specific Shifts
Read More

Lower-Cost Care Settings Can Offer Better Value
Read More

Whether a Market Has an Oversupply or Undersupply of Hospital Beds Is Defined by Market-Level Demographic and Demand Characteristics
Read More

Whether a Market Has an Oversupply or Undersupply of Hospital Beds Is Defined by Market-Level Demographic and Demand Characteristics
Read More

Increased Patient Volumes for Select Skin Conditions Align With Evolving Dermatologic Treatment Patterns
Read More

Telehealth Demand: An Update Four Years After the Onset of the COVID-19 Pandemic
Read More

Liver-Related Mortality and Healthcare Utilization Among Younger Men Is Growing
Read More

The Marked Shift in Urgent Care Utilization: Two Years Later
Read More

Analyzing the Wide Range of Value for High-Volume Outpatient Preventive Procedures
Read More

Exploring Reimbursement Differences Between Nonprofit and For-Profit Health Systems
Read More

Exploring Reimbursement Differences Between Nonprofit and For-Profit Health Systems
Read More

Match Day 2024: Primary Care Residency Positions Continue to Go Unfilled
Read More

Leveraging Risk Adjustment to Analyze Health Status of Patients Receiving Cancer Treatment in 2017 and 2022
Read More

The Factors Influencing Cancer Disease Burden Are Evolving
Read More

Local Analysis of Nonalcoholic Steatohepatitis Underscores Need for Targeted Treatment
Read More

Part 2: Harnessing Price Transparency Data to Analyze True Cost of Care
Read More

Part 1: The Economic Framework of Price Transparency Data
Read More

The Market Rate Has Been Revealed, and It Is Lower Than You Think
Read More

GLP-1 Utilization in New York City Is Not Correlated with Clinical Indication
Read More

The Cell and Gene Patient Journey Is Determined by Access to Treatment Sites
Read More

Employers Have a Critical Role in Containing U.S. Healthcare Spending
Read More

National Distribution Reveals Variation in Quality, Financial and Competitive Performance Among Renowned U.S. Hospitals
Read More

While Originally Intended for Consumers, Health Plan Price Transparency Will Ultimately Promote Value-Based Competition
Read More

Patients Prescribed Drugs Like Ozempic® and Mounjaro® Have Increased Over 300%
Read More

Eating Disorders Among Child and Adolescent Patients Incrementally Spiked Following the Pandemic’s Onset
Read More

Life Science Investments Signal a Continued Focus on Oncology and Immunology
Read More

Most Behavioral Health Patients, Particularly Those with Alcohol or Substance Use Disorder, Do Not Receive Follow-Up Care After an Emergency Department Visit
Read More

Anxiety, Depression, Chronic Pain Among Common Diagnoses Preceding Endometriosis and PCOS Diagnosis
Read More

The Share of Younger New Patients Seeing Oncology Providers Is Increasing Over Time
Read More

Sharp Uptick in Adderall Prescribing for Adults Ages 22-44 Amid COVID-19 Pandemic
Read More






















.png)

















.png?width=171&height=239&name=2025%20Trends%20Report%20Nav%20(1).png)
